230
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Cyclic AMP-induced p53 destabilization is independent of EPAC in pre-B acute lymphoblastic leukemia cells in vitro

, , &
Pages 256-263 | Received 27 Feb 2011, Accepted 01 Apr 2011, Published online: 27 May 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Marie Tosolini, Frédéric Pont, Delphine Bétous, Emmanuel Ravet, Laetitia Ligat, Frédéric Lopez, Mary Poupot, Marc Poirot, Éric Pérouzel, Gérard Tiraby, Els Verhoeyen & Jean-Jacques Fournié. (2015) Human Monocyte Recognition of Adenosine-Based Cyclic Dinucleotides Unveils the A2a Gαs Protein-Coupled Receptor Tonic Inhibition of Mitochondrially Induced Cell Death. Molecular and Cellular Biology 35:2, pages 479-495.
Read now

Articles from other publishers (3)

Arman Ghorbani & Hamid Zand. (2020) A new mechanistic approach for cancer fighting of resveratrol. Gene Reports 19, pages 100600.
Crossref
Georges Kalouche, Céline Boucher, Annick Coste, Laurent Debussche, Cécile Orsini, Christophe Baudouin, Thomas Debeir, Xavier Vigé & William Rostène. (2016) Prostaglandin EP2 receptor signaling protects human trabecular meshwork cells from apoptosis induced by ER stress through down-regulation of p53. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1863:9, pages 2322-2332.
Crossref
Majid Safa, Kazem Mousavizadeh, Shekoofeh Noori, Arefeh Pourfathollah & Hamid Zand. (2014) cAMP protects acute promyelocytic leukemia cells from arsenic trioxide-induced caspase-3 activation and apoptosis. European Journal of Pharmacology 736, pages 115-123.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.